• January 23, 2008
    DURHAM, N.C.--The Poultry Health Division of Pfizer Animal Health provides innovative solutions to improve the health, productivity, and costs of the poultry industry. “Pfizer is excited about delivering innovative poultry health solutions,” says Jim Gerardot, Group Director of Global Marketing, EuAfME, Latin America and Mexico Commercial Operations. The total product offerings from the Poultry Health Division of Pfizermore...
  • January 19, 2007
    NEW YORK--Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) today announced the completion of its acquisition of Embrex, Inc. (Nasdaq: EMBX), an international agricultural biotechnology company known for its Inovoject(R) vaccine-delivery systems. Completion followed the Embrex shareholder meeting today at which Embrex shareholders approved the merger. The transaction has an aggregate equity purchase price of approximately $155 millionmore...
  • December 12, 2006
    RESEARCH TRIANGLE PARK, N.C.--Embrex(R), Inc., The In Ovo Company(R), (Nasdaq: EMBX) announced that a special meeting of its shareholders will be held on January 19, 2007 at 9:00 a.m. local time at its corporate headquarters at 1040 Swabia Court, Durham, North Carolina 27703 to consider and vote upon a proposal to approve and adopt the Agreement and Plan of Merger dated as of November 14, 2006, among Embrex, Inc., Pfizer Inc. and Eagle Mergermore...
  • November 15, 2006
    NEW YORK & RESEARCH TRIANGLE PARK, N.C.--Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) has agreed to acquire Embrex, Inc. (NASDAQ: EMBX), an international agricultural biotechnology company known for its Inovoject® vaccine-delivery systems, the companies announced today. Under the terms of the agreement, Pfizer will acquire through a merger 100 percent of the equity of Embrex for $17 per share in cash, makingmore...